Clinical Trials Logo

Neurilemmoma clinical trials

View clinical trials related to Neurilemmoma.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06163664 Not yet recruiting - Clinical trials for Vestibular Schwannoma

Role of ChatGPT in Vestibular Schwannoma Management

Start date: December 15, 2023
Phase: N/A
Study type: Interventional

Previous studies have demonstrated that patients frequently undergo significant decision conflict regarding major medical decisions in otolaryngology. There lack validated tools available for decision support for patients. While limited evidence has demonstrated that clinical decision support tools can alleviate decision conflict for patients with diagnosis in otolaryngology, conversational language models were not employed in these studies and may provide additional benefit in this context. This study seeks to evaluate the efficacy of using ChatGPT, a conversational language model with basic clinical knowledge, in alleviating decision conflict for patients with new diagnosis in otolaryngology. For this pilot study, vestibular schwannoma, a benign tumor that develops on the vestibular nerve with known clinical equipoise, has been chosen for the initial study diagnosis. Efficacy will be evaluated by comparison of responses to the Decisional Conflict Scale (DCS) and Satisfaction with Decision (SWD) scores between a group given training in ChatGPT and a control group (no ChatGPT training).

NCT ID: NCT06112509 Not yet recruiting - Clinical trials for Vestibular Schwannoma

Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery

Start date: January 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the vestibular effects of gamma-knife radiosurgery, as part of the treatment of vestibular schwannoma.

NCT ID: NCT05567341 Not yet recruiting - Clinical trials for Vestibular Schwannoma

Remote Ischemic Preconditioning in Vestibular Schwannoma Surgery

RIC-VS
Start date: October 1, 2022
Phase: N/A
Study type: Interventional

Vestibular schwannomas are primarily benign (WHO grade I) tumors originating from the Schwann cells of the vestibular nerve and are among the most common tumors of the skull base. Common treatment options are surgical tumor resection or targeted radiation therapy. The special challenge of surgical treatment is the functional preservation of the cranial nerves, especially the cochlear and facial nerves. Perioperative ischemia of the cochlea and cochlear nerve is postulated as the underlying mechanism of postoperative hearing loss. Ischemic preconditioning is a non-invasive procedure that triggers the release of vasoactive cytokines and mediators by repeated short-term induction of limb ischemia. Improved perfusion of critically perfused end organs as well as a reduction of cerebral infarct volumes has already been shown in other pathologies. In the planned study, possible neuroprotective effects of remote ischemic preconditioning on postoperative hearing as well as facial nerve function in patients with vestibular schwannomas will be examined.

NCT ID: NCT03097822 Not yet recruiting - Clinical trials for Vestibular Schwannoma

Response Prediction After GKS in Patients With Vestibular Schwannoma Using DCE MR Imaging

Start date: January 2017
Phase: N/A
Study type: Observational

Response Prediction after Gamma Knife Surgery (GKS) in Patients with Vestibular Schwannoma using Dynamic Contrast-Enhanced (DCE) MR Imaging